SEC Form 4/A · accession 0001450324-16-000010
AIM ImmunoTech Inc. · AIM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Thomas K. Equels
Officer — CEO,Pres,Exec Vice Chairman · Director
Period of report
Mar 11, 2016
Accepted (ET)
Mar 14, 2016 · 11:16 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000946644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 11, 2016 | P | 30,000 | $0.1564 | A | 1,444,548 | D | |
| Common StockF2 | Mar 11, 2016 | P | 10,000 | $0.1618 | A | 1,454,548 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1To correct the amount of securities beneficially owned following the reported transaction.
- F2To correct the amount of securities beneficially owned following the reported transaction.